Jinyuan Zhou1,2, De-Xue Fu3, Tingting Zhou1, Bachchu Lal, John Laterra, Peter van Zijl1,2
1Department of Radiology, Johns Hopkins
University, Baltimore, MD, USA; 2F.M. Kirby Research Center for
Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA; 3Department
of Oncology, Johns Hopkins University, Baltimore, MD, USA
Amide proton transfer (APT) imaging detects endogenous mobile proteins and
peptides in tissue using the chemical exchange-dependent saturation transfer
(CEST) sensitivity enhancement mechanism. We here show initial results
demonstrating that APT has potential as an early marker for visualizing changes
in cellular protein properties in vivo associated with tumor chemotherapy using
proteasome inhibitors.